Proteostasis Therapeutics Receives Orphan Drug Designation in the EU for PTI-428 for the Treatment of Cystic Fibrosis

Stock Information for Proteostasis Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.